Read the latest research articles and studies exploring the use of Deep TMS™ in various disorders.
BrainsWay is actively exploring expanded uses for Deep TMS across numerous psychiatric and neurological conditions.
Explore our active clinical trials below and reach out to the contacts listed to enroll.
Baycrest Health Sciences, Toronto, Canada Alzheimer’s disease is an increasing issue in the aging population with 66 million
Ben Gurion University of the Negev, Israel Stroke is among the principal causes of death worldwide and even in the best-case
Take Part in an FDA Approved Study for MDD with the latest Deep TMS Technology by BrainsWay About BrainsWay treatment (Deep TMS™) BrainsWay*
Learn more about how Deep TMS can provide relief to people suffering from Major Depressive Disorder and Obsessive-Compulsive Disorder.
Anxious depression has received a growing amount of attention, as a specific kind of depression that...
Short-term anxiety is a distressing (if subclinical) emotional state that most individuals go through...
Major depressive disorder (or MDD) can take different forms, with recent studies finding that certain...
View upcoming and on-demand educational webinars.
Underlying TMS clinical research and cases, Traditional TMS uses, Deep TMS advantages, and future field developments.
Dr. Doron Todder
Mental Health Hospital, Beer Sheva, Israel
Webinar covering the background of anxious depression as a condition, current treatment options, BrainsWay's clinical efficacy and Deep TMS protocol, comparisons to Figure-8 and medication studies, how to think about patient identification, and more.
Dr. Aron Tendler, MD, CBSM
Join us to discuss market access and OCD provider resources to drive demand. Other topics include best practices, evidence, coverage drivers, influencers, and more, as well as our resource center to assist with prior authorizations and appeals.
Hear firsthand from patients how BrainsWay’s innovative treatments have helped them.
Take an in-depth look at how BrainsWay’s technology works.